Diseases of the circulatory system.
Conditions
Interventions
Intervention 1: Injection of 5 micrograms TNG in 150 cc Mglomyn dye. Time: During angiography. Intervention 2: 150 cc Myglomyn dye was mixed with 5 micrograms strile water and was injectrd during angi
Prevention
Placebo
Injection of 5 micrograms TNG in 150 cc Mglomyn dye. Time: During angiography.
150 cc Myglomyn dye was mixed with 5 micrograms strile water and was injectrd during angiography.
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: signing informed consent, age between 20 and 75 years, no drug addiction, lack of brain vascular disease and systolic blood pressure above 100 mmHg, candidates for angiography, hemodynamic stability, Exclusion criteria: history of heart disease, history of hypertension
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: during angiography. Method of measurement: patient observation and expression.;Coronary artery spasm. Timepoint: during angiography. Method of measurement: angiography film.;Chest pain. Timepoint: during angiography. Method of measurement: Pain by the patient during angiography is reported ECG changes in addition to rising or down piece ST.;Systolic and diastolic blood pressure. Timepoint: during angiography. Method of measurement: monitoring intravascular pressure device that was attached to the patient during angiography.;Brady arrhythmia. Timepoint: during angiography. Method of measurement: ECG monitoring during angiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Masoumeh Sadeghi
Isfahan Cardiovascular Research Center/Isfahan University of medical Science
Outcome results
None listed